コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
6 , under conservative assumptions, 101 out of every 10 000 cases (99th percentile, 482) will develop s
10 nset for change in EDSS versus age found for every 10 years of age, EDSS recovery is reduced by 0.15
12 this model by estimating population sizes in every 10- m grid cell in Nigeria with national coverage.
13 for all costs included in the analysis, for every 100 admissions, use of the WHO checklist was estim
16 arate occasion, 0.32 mg/kg MCAM was injected every 12 days for 5 total injections to evaluate the eff
17 ix sites in the Laurentian Great Lakes basin every 12 days from January to December 2017 (inclusive).
18 ation with cytarabine received intravenously every 12 h at either 100 mg/m(2) for 20 doses or 1000 mg
21 only when Re >=1.6; when test cost was <=$3, every 14-day testing was cost-effective at all Re examin
22 dividual phenolic compounds were carried out every 15 days, and the most stable microcapsules were ac
24 ly quantify the behavior of individual cells every 2 minutes during Phallusia mammillata embryogenesi
25 FL injections followed by regular injections every 2 months) and two irregular treatment interval coh
28 venous daratumumab once weekly (cycles 1-2), every 2 weeks (cycles 3-6), and every 4 weeks thereafter
29 fusion of fluorouracil 2400 mg/m(2) repeated every 2 weeks (regimen one), or oxaliplatin 130 mg/m(2)
31 emaining doses of the first two cycles, then every 2 weeks for four cycles (cycles 3-6), and every 4
33 ratumumab (DARA SC) weekly in cycles 1 to 2, every 2 weeks in cycles 3 to 6, and every 4 weeks therea
41 can and were thereafter clinically evaluated every 2-4 months (years 1-2), then every 6 months (years
43 experiment, retinal blood flow was assessed every 20 s for 6 min during and after 3 min flicker ligh
45 75 mg/m(2) by body surface area) on day 1 of every 21-day cycle (control group; group 1); intravenous
46 y body surface area) on days 1, 8, and 15 of every 21-day cycle (group 2); or intravenous dose-fracti
50 ive intramuscular fulvestrant 500 mg (day 1) every 28 days (plus a loading dose on day 15 of cycle 1)
51 resonance images were obtained at baseline, every 3 days after exposure for 2 weeks, and then weekly
52 ed by repeated CCl(4) administration to rats every 3 days for 3 or 8 weeks, then challenged with LPS
54 r every 30 min, completed a sleepiness scale every 3 h, and filled a sleep diary every morning (rende
57 illance in stage I-III NSCLC but may be used every 3 months for the first year and every 6 months for
61 once per day or doxorubicin 75 mg/m(2) once every 3 weeks (<= 6 cycles) after being randomly assigne
62 Trastuzumab was administered intravenously every 3 weeks (8 mg/kg loading dose at first cycle, and
64 3 weeks), group 2 (carboplatin AUC5 or AUC6 every 3 weeks and 80 mg/m(2) paclitaxel weekly), or grou
65 usly plus pembrolizumab 200 mg intravenously every 3 weeks and six received the recommended phase 2 d
66 ose of 200 mg (n = 514) or placebo (n = 505) every 3 weeks for 1 year or until disease recurrence or
68 isplatin (75 mg/m(2); investigator's choice) every 3 weeks for four cycles, followed by pemetrexed ma
69 ous pembrolizumab (200 mg) or saline placebo every 3 weeks for up to 2 years (35 cycles); all patient
70 retion, and intravenous pembrolizumab 200 mg every 3 weeks for up to 2 years or until disease progres
71 ollowed by maintenance bevacizumab (15 mg/kg every 3 weeks in both groups) until disease progression
72 dyweight, once weekly during cycle one, once every 3 weeks in cycles two through nine, and once every
73 lus gemcitabine (1000 mg/m(2), days 1 and 8) every 3 weeks or six cycles of bevacizumab (10 mg/kg, da
74 rated web-response to pembrolizumab (200 mg) every 3 weeks plus chemotherapy (nab-paclitaxel; paclita
75 5 mg/m(2) per dose intravenously on days 1-2 every 3 weeks with sequence adjusted on the basis of tim
76 AUC6 and 175 mg/m(2) intravenous paclitaxel every 3 weeks), group 2 (carboplatin AUC5 or AUC6 every
78 brentuximab vedotin and nivolumab were given every 3 weeks, ipilimumab was given every 6 weeks in the
79 he clinical activity of pembrolizumab 200 mg every 3 weeks, without restriction on prior therapy.
86 xually transmitted infection (STI) screening every 3-6 months for men who have sex with men (MSM) usi
88 wk, 641 working adults logged their behavior every 30 min, completed a sleepiness scale every 3 h, an
89 bruary 2020, perfusate samples were obtained every 30 minutes during 50 dual-HOPE (D-HOPE) procedures
90 buprofen, ketoprofen, and tiaprofenic acid), every 30 minutes: 20%-30%-50% of daily therapeutic dose,
91 tic dose, for the moderate absorption group, every 30 minutes: for diclofenac 5%-15%-30%-50%, and for
95 ravenous haloperidol dose escalation at 2 mg every 4 h, neuroleptic rotation with chlorpromazine at 2
96 leptic rotation with chlorpromazine at 25 mg every 4 h, or combined haloperidol at 1 mg and chlorprom
99 at 12.5% maximal voluntary contraction once every 4 s and (2) high fibre recruitment, with contracti
100 ing every 8 weeks was non-inferior to dosing every 4 weeks (HIV-1 RNA >=50 copies per mL; 2% vs 1%) w
101 andomly assigned and treated with guselkumab every 4 weeks (n=128), guselkumab every 8 weeks (n=127),
102 were randomly assigned to receive guselkumab every 4 weeks (n=246), every 8 weeks (n=248), or placebo
103 /kg every 2 weeks (28-day cycles) and 480 mg every 4 weeks after cycle 4, was administered intravenou
104 -acting antiretroviral regimen injected once every 4 weeks for treatment or every 8 weeks pending app
105 er proportions of patients in the guselkumab every 4 weeks group (156 [64%] of 245 [95% CI 57-70]) an
106 er proportions of patients in the guselkumab every 4 weeks group (76 [59%] of 128 [95% CI 50-68]) and
107 versus placebo of 37% (95% CI 26-48) for the every 4 weeks group and 30% (19-41) for the every 8 week
108 rences vs placebo 31% [95% CI 22-39] for the every 4 weeks group and 31% [23-40] for the every 8 week
109 ight (2%, every 8 weeks group) and two (<1%, every 4 weeks group) confirmed virological failures (two
110 cycles 1-2), every 2 weeks (cycles 3-6), and every 4 weeks thereafter (28-day cycles) until progressi
111 3 weeks in cycles two through nine, and once every 4 weeks thereafter as maintenance therapy until di
114 arbepoetin given as a fixed dose (0.45 ug/kg every 4 weeks) versus administered according to a hemogl
115 ed liposomal doxorubicin (30 mg/m(2), day 1) every 4 weeks, both followed by maintenance bevacizumab
116 occurred in no patients receiving guselkumab every 4 weeks, four (3%) patients receiving guselkumab e
127 after their first arrest and then reassessed every 6 months for 36 months and again at 48 months.
128 mong 7 monitoring schemes tested, monitoring every 6 months for all subjects had the fewest months of
130 e used every 3 months for the first year and every 6 months for the second year in patients with stag
133 ccording to a standard protocol at baseline, every 6 months thereafter for 5 years, and subsequently
137 re given every 3 weeks, ipilimumab was given every 6 weeks in the ipilimumab group and every 12 weeks
143 group (156 [64%] of 245 [95% CI 57-70]) and every 8 weeks group (159 [64%] of 248 [58-70]) than in t
144 s group (76 [59%] of 128 [95% CI 50-68]) and every 8 weeks group (66 [52%] of 127 [43-61]) than in th
148 injected once every 4 weeks for treatment or every 8 weeks pending approval by regulatory bodies and
150 Cabotegravir plus rilpivirine long-acting every 8 weeks was non-inferior to dosing every 4 weeks (
151 eks, four (3%) patients receiving guselkumab every 8 weeks, and five (4%) patients receiving placebo.
159 ytohormone-mediated processes control almost every aspect of plant development from seed and bud dorm
160 ribonucleoprotein formation and function in every aspect of RNA metabolism, ranging from synthesis t
161 everal years toward understanding how almost every aspect of the immune system contributes to the exp
165 An analysis of these models reveals that in every case the life cycle assumptions entail local repro
171 certainty levels (+/-40%) within portions of every census tract, with median concentration increases
172 dern standards exhibit rapid growth releases every circa 30 years, most likely caused by regular unde
173 oronavirus 2 (SARS-CoV-2) has reached nearly every country in the world with extraordinary person-to-
176 the CoGEF method to systematically evaluate every covalent mechanophore reported to date and compare
178 greed that living with Sjogren syndrome made every day a challenge (adjusted odds ratio [OR] 3.81, 95
182 ightning strikes thousands of tropical trees every day, but is commonly assumed to be a minor agent o
191 solution structures representative of nearly every family of mechanically activated channel described
192 s between mutually exclusive interpretations every few seconds, a phenomenon known as bistable percep
193 ages drawn from one semantic category except every fifth image (occurring at a rate of 1.2 Hz) which
195 he procedure estimates the z-displacement in every frame and applies an intensity correction in which
196 356) have been contacted appropriately after every FTC, in 243 patients (68.3%; n=356) at least one F
197 phenotypic series, the expression profile of every gene can be correlated with the strength of the tr
198 notyping Consortium (IMPC) aims to knock out every gene in the mouse and comprehensively phenotype th
199 ircadian rhythms is a core feature of nearly every genetic, dietary, or environmental model of metabo
201 f-reports, medical records for all events at every hospital where the patient reported receiving care
203 sk genes, and explain, at least in part, why every HSV1-infected person is not equally likely to deve
205 e (Gal) derived by systematically exchanging every hydroxyl group by a fluorine atom, we developed a
208 and its surrounding milieu, and thus drives every interaction that this synthetic material has with
212 termine optimal growth temperature (OGT) for every known microbial species, organisms adapted to diff
213 mation but also quantitative information for every labeling channel and avoid the issue of ratio dist
216 Since much of the biological history of every living creature is shaped by its diseases, recogni
220 ver operating curves (ROCs) were plotted for every measurement and contrasted with the proposed LDF.
223 circadian clocks and metabolism with nearly every metabolic pathway in the mammalian liver under cir
225 n; on day 2, retinal blood flow was measured every minute for 20 min during and after 10 min systemic
226 ss scale every 3 h, and filled a sleep diary every morning (rendering >292,000 activity and >70,000 s
227 rmine the parcel-specific neurite lengths of every neuron type from representative morphologic recons
229 available to host a geological repository in every nuclear waste-generating country, but carbonate ro
234 to oral rimegepant 75 mg or matching placebo every other day for 12 weeks (double-blind treatment pha
235 randomly assigned to group 1 (1 TMP-SMZ dose every other day for 311 days) or group 2 (1 identical pl
238 (85% O(2)) were randomly assigned to receive every other day injections of recombinant Klotho or plac
239 injections of 15 mg pegcetacoplan monthly or every other month (EOM) or sham intravitreal injections
240 d Ventilator Free compares each patient with every other patient in a win-lose-tie for each compariso
241 croscopy were performed weekly for 10 weeks, every other week for an additional 6 weeks or until remo
249 ime prediction to build libraries containing every peptide in a proteome, and then refines those libr
250 Unfortunately, adverse effects accompany every pharmacologic intervention and may affect overall
252 ication of diffusion or protein recovery for every pixel in a given 2D slice, thus moving FRAP measur
256 ibosome synthesis platform to build and test every possible single nucleotide mutation within the PTC
257 on of fly strains to individually manipulate every proboscis muscle through control of its motor neur
261 developed using systematic reviews to inform every recommendation, as suggested by the Institute of M
262 rative model, the best possible template for every region of a target can be used expanding the confo
267 this flexibility results from the fact that every single gene of the GRN possesses its own functiona
275 doses given at baseline, alternate days, and every third day did not differ [12.7 (7.3, 21.9), 13.8 (
276 (QLQ-LC13) were administered at cycles 1-5, every three cycles thereafter during year 1, and every f
277 l components, netarsudil and latanoprost, at every time point assessed and an ocular tolerability pro
284 universal vote-by-mail-a policy under which every voter is mailed a ballot in advance of the electio
285 ied for automated segmentation of fluid with every voxel classified by a convolutional neural network
286 ed the entire brain directly in 3D, labeling every voxel with a brain structure spanning 43 isocortic
291 rs in which up-calls were detected increased every year, both during the peak season (from 38% in 200
292 human immunodeficiency virus type 1 (HIV-1) every year, but not all acquire the virus, suggesting a
294 , and (flash) floods - that affect this area every year, damaging population and infrastructures, are
295 or more than 50 million infections worldwide every year, with an overall increase of 30-fold in the l
300 posed to Mycobacterium tuberculosis globally every year; however, there are no contemporary estimates